Melanoma Cells Control Antimelanoma CTL Responses of melanoma via INTERACTION THROUGH TIGIT and CD155 in the Effector Phase
Melanoma Cells Control Antimelanoma CTL Responses via Interaction between TIGIT and CD155 in the Effector Phase.